Prof. Abdulwahab Ali Abuderman is a clinician-scientist whose research is rooted in gastrointestinal pathophysiology and cancer biology. His doctoral work at the University of Liverpool established a strong foundation in the molecular mechanisms of *Helicobacter pylori*-induced gastric carcinogenesis, a theme that continues to anchor his scientific output across 45+ peer-reviewed publications. His research interests extend into oncology at the molecular level, encompassing gene mutations in colorectal cancer, immunological abnormalities in haematological disorders, and biomarker profiling in breast cancer. A recurring thread across his work is the application of cell biology and immunohistochemistry to elucidate cancer hallmarks, including investigations into natural compound bioactivity and nanoparticle-based anti-tumour agents. Parallel to his laboratory interests, Prof. Abuderman has sustained a scholarly engagement with medical education — particularly curriculum design, simulation-based clinical training, and competency assessment across undergraduate and postgraduate levels. More recently, his academic focus has expanded to encompass healthcare management, health systems innovation, and the integration of artificial intelligence in clinical and educational contexts, reflecting both his C-suite leadership experience and his ongoing MSc studies at RCSI. These converging interests position him at the nexus of translational science, eeducational, and healthcar innovation